AestheticMedGuide: Service Evidence to Request When a Used Laser Changes Hands

When healthcare technology management (HTM) or service personnel are asked to evaluate a resold aesthetic laser, the first job is to reconstruct three evidence buckets before anyone treats the unit as accepted: sale inventory that can be inspected on the device; retained service history that exists as a dated record from a named source; and manufacturer, configuration, accessory, or software and licensing facts that are still missing. A bill of sale, broker invoice, or freight list confirms that physical goods changed hands. It is not a service-history file, not an inspect-and-test finding, and not proof that user information or servicing instructions traveled with the laser.

This article is a seller-to-buyer service-evidence index. It is not a used-laser buying or return-on-investment guide, not a 510(k) lookup tutorial, not title-transfer or recertification-fee advice, not a generic first-use incoming-inspection checklist, not a loaner-custody worksheet, not a work-order contents list, and not a supplier-qualification protocol. It does not provide service passwords, original-equipment-manufacturer (OEM) restriction bypass, repair or calibration steps, or unauthorized restoration. It does not assume that software licenses, keys, or service entitlements transfer with title. It does not issue a patient-ready, clearance, or return-to-service finding from the handover index.

Clinic purchasers sometimes read adjacent commercial context on AestheticMedGuide's due diligence guide on buying used aesthetic lasers. AestheticMedGuide is a publication. It is not a broker, service contractor, regulator, or proof of clearance. That page does not close an HTM record and is not an authority for clearance, license transfer, or return-to-service.

21 CFR 1010.3(a), displayed on eCFR and last amended 20 January 2023 (88 FR 3653), requires every manufacturer of an electronic product to which a Subchapter J standard applies to set forth specified identification on a tag or label permanently affixed or inscribed on the product so as to be legible and readily accessible to view when the product is fully assembled for use. The label must include the manufacturer's full name and address; abbreviations such as “Co.” or “Inc.” and first and middle initials of individuals may be used. Where the product is sold under a name other than that of the manufacturer, that name and address may be set forth if the Center for Devices and Radiological Health (CDRH) has previously been given enough information to identify the manufacturer. The label must also include the place and the month and year of manufacture, with the year as a four-digit number and without abbreviation, unless an FDA-recognized consensus-standard date format is used. Place of manufacture may be expressed in code if the manufacturer has previously supplied CDRH with the key; a hospital reader cannot decode a code from this section alone. A used-laser listing that copies only a broker stock-keeping unit or chassis serial without those identification fields is missing product identity. It is not a completed service history. eCFR is unofficial.

21 CFR 1010.2(a) through (c) requires the manufacturer of an electronic product for which an applicable Subchapter J standard is in effect to furnish, at delivery to the dealer or distributor, certification that the product conforms to all applicable standards. The certification must be a permanently affixed or inscribed English-language label or tag that is legible and readily accessible when the product is fully assembled for use, based on a test of the individual article or on a testing program in accordance with good manufacturing practices. That certification label is a sale-inventory field that can be inspected on the device. It is not prior-owner work-order evidence, and it is not a hospital inspect-and-test finding.

21 CFR 1040.10 applies, with § 1040.11, to laser products manufactured or assembled after 1 August 1976. 21 CFR 1040.10(g)(10) requires labels required by that section and by § 1040.11 to be permanently affixed to or inscribed on the laser product, legible, and clearly visible during operation, maintenance, or service as appropriate. 21 CFR 1040.10(g)(4) requires each Class II, III, and IV laser product to state, at position 2 on the warning logotype, the maximum output of laser radiation, the pulse duration when appropriate, and the laser medium or emitted wavelength(s). Nameplate class, aperture, and identification labels are therefore sale-inventory fields that can be inspected on the device. They are not substitutes for prior service records. Recording that a logotype is present is not an output-measurement or return-to-service finding. Labeled maximum output is not an HTM pass/fail value, and this article does not invent numeric output limits.

21 CFR 1040.10(b)(26) defines a medical laser product as a laser product that is a medical device under 21 U.S.C. 321(h) and is manufactured, designed, intended, or promoted for in vivo laser irradiation of any part of the human body for diagnosis, surgery, or therapy, or for relative positioning of the human body. 21 CFR 1040.11(a) requires each medical laser product to comply with applicable § 1040.10 requirements for its class and, additionally, that the manufacturer (1) incorporate in each Class III or IV medical laser product a means for the measurement of the level of that laser radiation intended for irradiation of the human body, with indication in International System Units; (2) supply with each Class III or IV medical laser product instructions specifying a procedure and schedule for calibration of that measurement system; and (3) affix, in close proximity to each aperture through which accessible laser radiation in excess of Class I limits is emitted, a label bearing the wording “Laser aperture.” Accessory, delivery, and measurement-system identity is therefore distinct from the console serial on a sales invoice. Do not convert the regulation's manufacturer measurement-error allowance into an HTM numeric output limit. This article does not supply calibration or output-test steps.

A frequent intake error is treating the console serial as if it named every included handpiece, delivery accessory, or Class III or IV measurement means. Aesthetic platforms often ship modular delivery heads as separate physical objects. A reseller line that says only “aesthetic laser system with handpieces” does not identify those parts. Record each included delivery accessory or measurement means as its own evidence object, or mark the identity unknown. A pulse-count claim on a listing is not a 21 CFR identity field and is not a completed service history.

21 CFR 1040.10(b)(24) defines maintenance as adjustments or procedures specified in manufacturer user information to be performed by the user. 21 CFR 1040.10(b)(38) defines service as procedures or adjustments described in the manufacturer's service instructions that may affect performance for which §§ 1040.10 and 1040.11 have applicable requirements. Neither definition converts a bill of sale into either packet.

Under 21 CFR 1040.10(h)(1), manufacturers must provide, as an integral part of any user instruction or operation manual regularly supplied with the product or otherwise with each laser product, adequate instructions for assembly, operation, and maintenance, including a schedule of maintenance necessary to keep the product in compliance with §§ 1040.10 and 1040.11, plus reproductions of required labels. 21 CFR 1040.10(h)(2)(ii) separately requires manufacturers to provide, to servicing dealers and distributors and to others upon request at a cost not to exceed the cost of preparation and distribution, adequate instructions for service adjustments and service procedures for each laser product model, including a schedule of maintenance necessary to keep the product in compliance with §§ 1040.10 and 1040.11, and a listing of controls and procedures that could increase accessible emission levels. A change-of-hands packet that lacks that user information or that servicing information still has a named gap. A bill of sale does not prove either packet traveled with the laser. Availability of servicing instructions upon request is not the same as retained prior-owner service history.

Centers for Medicare & Medicaid Services (CMS) Survey-and-Certification memorandum S&C: 14-07-Hospital states that all equipment must be inspected and tested for performance and safety before initial use and after major repairs or upgrades, and that all equipment must be inspected, tested, and maintained to ensure safety, availability, and reliability. Medical equipment in the memo includes devices intended for diagnostic, therapeutic, or monitoring care. The same memo identifies a medical laser device as equipment discussed in that maintenance context and then states, as CMS interpretive language:

It should be noted that for medical lasers the U.S. Food and Drug Administration requires manufacturers to provide a schedule of maintenance and adequate instructions for service adjustments and service procedures to purchasers and, at cost, to any other parties requesting them.

That sentence is CMS paraphrase of FDA duties. It must not be collapsed into 21 CFR 1040.10(h) as if user manuals under (h)(1) and servicing instructions under (h)(2)(ii) were the same packet. User information under (h)(1) is to be provided with each laser product. Servicing instructions under (h)(2)(ii) are owed to servicing dealers and distributors and to others upon request at cost.

42 CFR 482.41(d)(2) currently requires that facilities, supplies, and equipment must be maintained to ensure an acceptable level of safety and quality. CMS Quality, Safety and Oversight memorandum QSO-25-24-Hospitals, original release 5 September 2025, recodifies Tag A-0724 to § 482.41(d)(2) and still cites S&C memo 14-7. In the QSO-25-24 interpretive text, all equipment should be inspected and tested for performance and safety before initial use and after major repairs or upgrades, and all equipment must be inspected, tested, and maintained to ensure its safety, availability, and reliability. Quote should as should and must as must. Neither document invents a universal numeric definition of major repair. A bill of sale and a serial number copied into a computerized maintenance management system (CMMS) are not the inspect-and-test finding, and they do not prove the FDA-required servicing information is in the handover packet. This worksheet does not decide Alternate Equipment Management eligibility; that is a different published job.

21 CFR 807.92(a), last amended 14 December 1994, requires a 510(k) summary to state, among other things, the name of the device, including the trade or proprietary name if applicable, the common or usual name, and the classification name if known, and a statement of the intended use of the device, including a general description of the diseases or conditions the device will diagnose, treat, prevent, cure, or mitigate and, where appropriate, the patient population. A used-laser invoice that says only “aesthetic laser” is not that device-identity record. Section 807.92 is a manufacturer premarket-notification content rule. It is not a hospital 510(k) filing duty, not proof of current clearance status from an invoice, and not a clinic-purchaser 510(k) lookup, title-transfer, or recertification-fee workflow.

21 CFR 1040.10(i) states that modification of a laser product previously certified under § 1010.2, by any person engaged in the business of manufacturing, assembling, or modifying laser products, shall be construed as manufacturing under the Act if the modification affects any aspect of the product's performance or intended function(s) for which §§ 1040.10 and 1040.11 have an applicable requirement, and that the manufacturer who performs such modification shall recertify and reidentify the product under §§ 1010.2 and 1010.3. Claimed modifications, added handpieces, or undocumented hardware changes are therefore a separate evidence row from chassis identity and from prior service logs. Record whether a modification is claimed and whether recertification or reidentification evidence is present. This article does not retell the published servicing-versus-remanufacturing six-principle tree, does not decide that a given change is remanufacturing, and does not provide modification or interlock-defeat procedures.

21 CFR 801.3 defines a unique device identifier as a device identifier plus a production identifier. The production identifier may include the serial number of a specific device and, separately, the lot or batch, expiration date, and date of manufacture when those elements are included on the label. Lot or batch means finished devices of a single type, model, class, size, composition, or software version manufactured under essentially the same conditions. A chassis serial copied from a sale listing is therefore not the software-version field and not software-licensing evidence. Version or model means all devices that have specifications, performance, size, and composition within limits set by the labeler. Software version in the lot-or-batch definition is a manufacturing-grouping attribute, not a listed production-identifier element named “software version.” Do not assume software keys, licenses, or service-software entitlements transfer with title. Record whether software-version or licensing evidence is present; leave it unknown when it is not. This is not the published after-restore before-and-after configuration-provenance worksheet.

FDA's Remanufacturing of Medical Devices final guidance, issued 10 May 2024, is current Agency thinking. It does not establish rights and is not binding on FDA or the public; an alternative approach may be used if it satisfies applicable statutes and regulations. Guidances should be viewed only as recommendations unless a specific regulatory or statutory requirement is cited. The word should means suggested or recommended, not required. The guidance encourages OEMs, as an industry best practice and not as a trade-secret disclosure duty, to provide servicing instructions for reusable devices. OEM labeling of reusable devices should include, as applicable, a description of key performance and safety specifications; device-specific performance specifications such as wavelength; recommended maintenance activities and schedule; recommended troubleshooting steps, routine testing, and acceptance criteria; precautions and warnings relevant to servicing; and the version number and release date of software. Those labeling fields are inputs to the handover index. They are not proof that a given used unit's software license is transferable, not a completed service history, and not return-to-service.

Use the index below to keep those fields from collapsing into one invoice line. Fill cells with observed facts. Mark blank cells as unknown, not as fail, not as unsafe, and not as proof that no record exists. The index does not replace inspect-and-test before initial use.

The operational application of this framework is demonstrated through an explicitly hypothetical dossier. The facility, seller, manufacturer, model, and serial values below are invented. This example is not an actual device, clearance, license transfer, or return-to-service decision.

This index is a different job from generic work-order contents in Medical Equipment Service Records: What a Work Order Must Contain, supplier approval in How to Qualify a Medical Equipment Service Provider: An Evidence Checklist, the May 2024 six-principle activity-classification tree in Medical Device Servicing vs Remanufacturing: How to Draw and Document the Boundary, survey unique identification in CMMS Medical Equipment Inventory: Unique Identification and Survey Requirements, and the after-restore software and configuration provenance matrix in MedDeviceGuide: Recording Configuration After a Software Restore. CMS inspect-and-test before initial use remains a later finding this index cannot replace. Adjacent clinic-purchaser commercial context remains on AestheticMedGuide's due diligence guide on buying used aesthetic lasers; that publication still does not close the HTM record. By isolating inspectable sale inventory from retained service history and naming manufacturer, accessory, and software facts that are still missing, HTM can record what remains unknown before anyone treats the unit as accepted.

• 21 CFR 1010.3 — Identification: Requires a permanently affixed manufacturer name and address and the place, month, and four-digit year of manufacture for electronic products subject to a Subchapter J standard.

• 21 CFR 1010.2 — Certification: Requires a permanently affixed English-language manufacturer certification, at delivery to the dealer or distributor, that the product conforms to applicable Subchapter J standards.

• 21 CFR 1040.10 — Laser products: Performance standard for laser products, including warning-logotype information, user information provided with each product, servicing instructions available on request, and recertification after covered modification.

• 21 CFR 1040.11 — Specific purpose laser products: Adds, for medical lasers, a Class III/IV measurement means with SI indication, calibration-procedure and schedule instructions for that measurement system, and a “Laser aperture” label.

• 21 CFR 807.92 — Content and format of a 510(k) summary: Manufacturer premarket-notification content rule for device name and intended use. It is not a hospital filing duty and not proof of current clearance from an invoice.

• 21 CFR 801.3 — Definitions: Separates unique-device-identifier serial number from lot or batch, and includes software version in the lot-or-batch definition as a manufacturing grouping.

• FDA Guidance on Remanufacturing of Medical Devices (10 May 2024): Nonbinding recommendations that reusable-device labeling should include servicing-related specifications, maintenance schedule, routine testing and acceptance criteria, and software version and release date.

• CMS S&C: 14-07-Hospital: Interpretive memorandum stating that all equipment must be inspected and tested before initial use and after major repairs or upgrades, with a medical-laser note paraphrasing FDA servicing-information duties.

• CMS QSO-25-24-Hospitals (Tag A-0724): Interpretive guidelines under 42 CFR 482.41(d)(2) stating that equipment should be inspected and tested before initial use and must be maintained for safety, availability, and reliability.

• 42 CFR 482.41 — Condition of participation: Physical environment: Requires facilities, supplies, and equipment to be maintained to ensure an acceptable level of safety and quality.